Therapeutic effect of nintedanib on acute exacerbation of interstitial lung diseases

Although the development of new antifibrotic agents (pirfenidone, nintedanib) has modified the disease progression of idiopathic pulmonary fibrosis (IPF), there is still no effective treatment for acute exacerbation of interstitial lung diseases (ILD) including IPF. We herein report a case of acute...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Yoko, Tazaki, Gen, Kondo, Yusuke, Takahashi, Genki, Sakamaki, Fumio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409392/
https://www.ncbi.nlm.nih.gov/pubmed/30931251
http://dx.doi.org/10.1016/j.rmcr.2019.02.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409392/
https://www.ncbi.nlm.nih.gov/pubmed/30931251
http://dx.doi.org/10.1016/j.rmcr.2019.02.021

Ejemplares similares